Obstructive & Interstitial Lung Disease, Respiratory Failure and Cystic Fibrosis

Final Year MBBS • CVS Module • Rapid relationship-based integration

1. THE TOPIC IN ONE CONNECTED FLOW

Respiratory symptoms in this topic arise from three linked problems: narrowed airways, stiff or damaged lung parenchyma, and failure of oxygenation or ventilation. The key is to connect the underlying mechanism with the clinical pattern, pulmonary function tests, ABG interpretation and treatment.

Cause / Trigger

Airway inflammation, harmful inhalational exposure, interstitial injury or CFTR dysfunction

→

Core Mechanism

Airway narrowing, loss of elastic recoil, fibrosis or thick airway secretions

→

Functional Change

Obstruction, restriction, impaired diffusion or inadequate alveolar ventilation

→

Clinical Presentation

Wheeze, cough, progressive dyspnea, dry cough, hypoxemia or respiratory distress

→

Diagnostic Clue

PFT pattern, imaging, ABG, clinical context or sweat chloride / genetic assessment

→

Management Target

Bronchodilation, inflammation control, exposure removal, oxygen, ventilatory support or airway clearance

→

Outcome / Complication

Improved airflow and gas exchange or progression to respiratory failure and chronic lung damage

2. KEY CLINICAL CONNECTIONS

Obstructive Disease Connection

Asthma: airway inflammation + bronchoconstriction → variable obstruction → episodic wheeze → reversible airflow limitation.

COPD: chronic exposure → small-airway disease + alveolar damage → persistent obstruction → progressive dyspnea → reduced FEV₁/FVC.

Restriction & Gas Exchange Connection

Interstitial injury → fibrosis → reduced compliance → restrictive physiology → progressive breathlessness.

Alveolar-capillary thickening → impaired diffusion → exertional hypoxemia → possible chronic respiratory failure.

Respiratory Failure & Oxygen Connection

Impaired oxygen transfer → Type I pattern → hypoxemia → oxygen therapy.

Inadequate alveolar ventilation → CO₂ retention → Type II pattern → ABG reassessment + ventilatory support when needed.

Cystic Fibrosis Connection

CFTR dysfunction → dehydrated secretions → impaired mucus clearance → recurrent infection and inflammation.

Persistent airway injury → bronchiectatic damage → declining respiratory function → airway clearance and multidisciplinary management.

3. AIM HIGH-YIELD INTEGRATION REVIEW

⭐ Variable symptoms + reversible airflow limitation → supports asthma; persistent obstruction + exposure history → supports COPD.

Bronchial asthma → airway inflammation and bronchoconstriction → wheeze; cardiac asthma → pulmonary congestion → wheeze with orthopnea and other heart-failure features.

⭐ Reduced FEV₁/FVC → obstructive physiology; reduced lung volumes with preserved/increased ratio → restrictive physiology.

ILD → fibrosis → reduced compliance + impaired diffusion → dry cough, progressive dyspnea and hypoxemia.

⭐ Hypoxemia without primary CO₂ retention → Type I respiratory failure; hypoventilation with CO₂ retention → Type II respiratory failure.

ABG pattern → pH + PaCO₂ + bicarbonate + PaO₂ → distinguishes acute disturbance, chronic compensation and oxygenation failure.

Oxygen therapy → treats hypoxemia → delivery method depends on clinical need → patients at risk of hypercapnia require controlled administration and reassessment.

⭐ CFTR dysfunction → thick secretions → poor clearance → infection/inflammation → airway damage; sweat chloride and genetic evaluation support diagnosis.

AIM Exam Trap:
A reduced FVC does not automatically mean restriction. If the FEV₁/FVC ratio is reduced, an obstructive component is present; true restriction requires assessment of lung volumes.